Home / Financial Results / Ferozsons Laboratories Limited’s financial result for the first quarter ended September 30, 2011

Ferozsons Laboratories Limited’s financial result for the first quarter ended September 30, 2011

Karachi: We have to inform you that the Board of Directors of our company in their meeting held on October 29, 2011 at 2:00 P.M. at 197-A, The Mall, Rawalpindi has not recommended interim cash dividend/bonus shares and/or right shares.

Company’s individual Profit and Loss Account (un-audited) for the first quarter ended September 30, 2011 with comparison of corresponding quarter of the last year is enclosed.

The Share Transfer Books of the Company will not be closed.

Condensed Interim Profit and Loss Account (Un-Audited) For The Three months Ended September 30, 2011

 

Quarter Ended

Quarter Ended

September 30, 2011

September 30, 2010

Note

(Rupees)

(Rupees)

Sales- net 394,650,964 271,484,333
Cost of sales 11  (181,064,982) (116,127,786)
———– ———–
Gross profit  213,585,982 155,356,547
Other operating income 15,208,282 17,488,481
Administrative expenses (34,917,152) (23,465,518)
Selling and distribution cost  (86,947,026) (57,548,137)
Finance cost (2,365,545)  (3,009,773)
Other charges  (8,439,587)  (7,780,504)
Share in profit of Farmacia – 98% owned partnership firm 2,143,837  1,788,198
———– ———–
Profit before taxation 98,268,792 82,829,294
Provision for taxation   (1,990,091) (138,026)
———– ———–
Profit after taxation 96,278,700 82,691,269
———–  ———–
Earnings per share – basic and diluted 3.85 3.31

 

For more information, contact:
Ferozsons Laboratories Limited
5-KM Sunder Raiwind Road
Raiwind Lahore- Pakistan
Office Ph: +92-42-32104001-3
Fax: +92-42-32104004
Email: info@ferozsons-labs.com

Leave a Reply

Scroll To Top